Bulletin
Investor Alert

New York Markets Open in:

Market Sentiment (Stocks on NYSE, NASDAQ, AMEX)
Unchanged
231
Decliners
4367
Advancers
2189

Dec. 21, 2016, 3:27 p.m. EST

4 stocks to watch

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Clovis Oncology Inc. (CLVS)
  • X
    Ferroglobe PLC (GSM)
  • X
    Supernus Pharmaceuticals Inc. (SUPN)

or Cancel Already have a watchlist? Log In

About Harry Boxer

Harry Boxer is author of TheTechTrader.com, a real-time diary of his trading ideas and technical market analysis. He has more than 40 years of Wall Street investment and technical analysis experience, including eight years on Wall Street as chief technical analyst with three brokerage firms. Former chief technical analyst and columnist for AmericaInvest.com and winner of the 1995 & 1996 worldwide Internet stock-market trading contest, "The Technical Analysis Challenge," Harry is widely syndicated and a featured guest on many financial programs and sites.

/conga/trading-deck/bios/boxer_harry.html 258063
Harry Writes About
Stocks
Harry's latest posts
View all
The trading deck is powered by

By Harry Boxer

Here are four momentum charts to watch.

Clovis Oncology

Clovis Oncology Inc. /zigman2/quotes/201295534/composite CLVS -3.78%  had a very good day on Tuesday, up 2.04, or 5%, to 42.52 on four million shares traded. The move closed the stock above lateral resistance at 40.00, and positioned it right at the top of the mini two-month rising channel within its longer-term up channel. A follow-through on Wednesday could lead to 46.00 and then 49.00 next.

Check out Harry’s video analysis of this stock on the last page.

/zigman2/quotes/201295534/composite
US : U.S.: Nasdaq
$ 6.37
-0.25 -3.78%
Volume: 4.38M
July 13, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$582.50 million
Rev. per Employee
$203,821
loading...
This Story has 0 Comments
Be the first to comment
More News In
Trading Deck

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.